European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

‘Your Heart Forecast’: a new approach for describing and communicating cardiovascular risk?

Wells, S. R., Kerr, A., Eadie, S., Wiltshire, C., & Jackson, R. (2010) · Heart · doi:10.1136/hrt.2009.191320 · Cited by 60

Avoiding crisis-driven business failure through digital dynamic capabilities. B2B distribution firms during the COVID-19 and beyond

Zia, N. U., Shamim, S., Zeng, J., Awan, U., Chromjaková, F., Akhtar, P., & Orel, M. (2023) · Industrial Marketing Management · doi:10.1016/j.indmarman.2023.05.015 · Cited by 59

Accuracy of the screening physical examination to identify subclinical atherosclerosis and peripheral arterial disease in asymptomatic subjects

Cournot, M., Boccalon, H., Cambou, J., Guilloux, J., Taraszkiewicz, D., Hanaire, H. P., Chamontin, B., Galinier, M., & Ferrières, J. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.08.022 · Cited by 57

Management of Cardiovascular Disease Risk Factors in Individuals with Chronic Spinal Cord Injury: An Evidence-Based Review

Cragg, J. J., Stone, J. A., & Krassioukov, A. V. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2313 · Cited by 59

Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk

Deckers, J. W., Goedhart, D. M., Boersma, E. H., Briggs, A. H., Bertrand, M. E., Ferrari, R., Remme, W. J., Fox, K. M., & Simoons, M. L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi809 · Cited by 58

Pharmacogenomics of Statin Responsiveness

Kajinami, K., Akao, H., Polisecki, E. Y., & Schaefer, E. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.011 · Cited by 58

Overview of Risk Prediction Models in Cardiovascular Disease Research

Cui, J. S. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.05.005 · Cited by 60

Cardiovascular disease risk in adults with spastic bilateral cerebral palsy

van der Slot, W. M. A., Roebroeck, M. E., Nieuwenhuijsen, C., Bergen, M. P., Stam, H. J., Alex Burdorf, A., & van den Berg-Emons, R. J. G. (2013) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-1185 · Cited by 59

A review of the information needs of patients with acute coronary syndromes

Timmins, F. (2005) · Nursing in Critical Care · doi:10.1111/j.1362-1017.2005.00125.x · Cited by 58

Insulin resistance is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes

Pané, A., Conget, I., Boswell, L., Ruiz, S., Viñals, C., Perea, V., Giménez, M., Cofán, M., Blanco, J., Vinagre, I., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3323 · Cited by 60

Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the heart

Anselmino, M., Bartnik, M., Malmberg, K., Rydén, L., & on behalf of the Euro Heart Survey Investigators (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000199496.23838.83 · Cited by 56

From pathophysiology to targeted therapy for atherothrombosis: A role for the combination of statin and aspirin in secondary prevention

Chapman, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.005 · Cited by 57

Risk scoring in the assessment of cardiovascular risk

Beswick, A. D., & Brindle, P. M. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000236362.56216.44 · Cited by 59

Effect of fermented milk containingLactobacillus acidophilusandBifidobacterium longumon plasma lipids of women with normal or moderately elevated cholesterol

Andrade, S., & Borges, N. (2009) · Journal of Dairy Research · doi:10.1017/s0022029909990173 · Cited by 57

n-3 Fatty Acids: Food or Supplements?

Kris‐Etherton, P. M., & Hill, A. M. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.04.025 · Cited by 56

Alcohol consumption and risk of recurrent cardiovascular events and mortality in patients with clinically manifest vascular disease and diabetes mellitus: The Second Manifestations of ARTerial (SMART) disease study

Beulens, J. W. J., Algra, A., Soedamah‐Muthu, S. S., Visseren, F. L. J., Grobbee, D. E., & van der Graaf, Y. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.034 · Cited by 56

Effects of Poly-Bioactive Compounds on Lipid Profile and Body Weight in a Moderately Hypercholesterolemic Population with Low Cardiovascular Disease Risk: A Multicenter Randomized Trial

Solà, R., Valls, R. M., Puzo, J., Calabuig, J.-R., Brea, Á., Pedret, A., Moriña, D., Villar, J. R., Millán, J., & Anguera, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101978 · Cited by 56

Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America

Schmermund, A., Lehmann, N., Bielak, L. F., Yu, P., Sheedy, P. F., Cassidy‐Bushrow, A. E., Turner, S. T., Moebus, S., Möhlenkamp, S., Stang, A., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.04.009 · Cited by 56

Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: The SardiNIA Study

Scuteri, A., Najjar, S. S., Orrù, M., Albai, G., Strait, J., Tarasov, K. V., Piras, M. G., Cao, A., Schlessinger, D., Uda, M., et al. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.11.004 · Cited by 57

Effect of a low dose of sea buckthorn berries on circulating concentrations of cholesterol, triacylglycerols, and flavonols in healthy adults

Larmo, P. S., Yang, B., Hurme, S. A. M., Alin, J., Kallio, H. P. T., Salminen, E. K., & Tahvonen, R. L. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0011-4 · Cited by 56

Therapeutic Goal Attainment in Patients With Hypertension and Dyslipidemia

Johnson, M. L., Pietz, K., Battleman, D. S., & Beyth, R. J. (2005) · Medical Care · doi:10.1097/01.mlr.0000188982.25397.37 · Cited by 55

Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?

Robinson, J. G., Bakris, G. L., Torner, J., Stone, N. J., & Wallace, R. B. (2006) · Stroke · doi:10.1161/01.str.0000254602.58896.d2 · Cited by 55

Young Adults With Family History of Coronary Heart Disease Have Increased Arterial Vulnerability to Metabolic Risk Factors

Juonala, M., Viikari, J. S. A., Räsänen, L., Helenius, H. Y. M., Pietikäinen, M., & Raitakari, O. T. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000222012.56447.00 · Cited by 56

The Role of Nutritional Status in Elderly Patients with Heart Failure

Wleklik, M., Uchmanowicz, I., Jankowska‐Polańska, B., Andreae, C., & Regulska−Ilow, B. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0985-1 · Cited by 60

A comprehensive workplace intervention and its outcome with regard to lifestyle, health and sick leave: The AHA study

Bergström, G., Björklund, C., Fried, I., Lisspers, J., Nathell, L., Hermansson, U., Helander, A., Bodin, L., & Jensen, I. B. (2008) · Work · doi:10.3233/wor-2008-00722 · Cited by 55

Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders

Calafato, S., Thygesen, J. H., Ranlund, S. M., Zartaloudi, E., Cahn, W., Crespo‐Facorro, B., Díez, Á., Forti, M. D., Hall, M., Iyegbe, C. O., et al. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.89 · Cited by 55

Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists. Results from a physician survey in Germany

Heidrich, J., Behrens, T., Raspe, F., & Keil, U. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000183913.82612.0e · Cited by 61

Prevalence and predictors of subclinical atherosclerosis among asymptomatic “low risk” individuals in a multiethnic population

Grewal, J., Anand, S. S., Islam, S., & Lonn, E. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.06.020 · Cited by 55

Reproductive History, Oral Contraceptive Use, and the Risk of Ischemic and Hemorrhagic Stoke in a Cohort Study of Middle-Aged Swedish Women

Yang, L., Kuper, H., Sandin, S., Margolis, K. L., Chen, Z., Adami, H., & Weiderpass, E. (2009) · Stroke · doi:10.1161/strokeaha.108.531913 · Cited by 53

Metabolic syndrome related to cardiovascular events in a 10-year prospective study

Kazlauskienė, L., Butnorienė, J., & Norkus, A. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0096-2 · Cited by 54

Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905–1977 in the population-based Tromsø Study 1979–2016

Hopstock, L. A., Bønaa, K. H., Eggen, A. E., Grimsgaard, S., Jacobsen, B. K., Løchen, M., Mathiesen, E. B., Njølstad, I., & Wilsgaard, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015001 · Cited by 59

Cardiovascular disease in rheumatoid arthritis: Single-center hospital-based cohort study in France

Assous, N., Touzé, E., Meune, C., Kahan, A., & Allanore, Y. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.10.001 · Cited by 53

Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis

Tkáč, I. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.002 · Cited by 54

Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care (protocol)

Loon, M. S. K.-V., van Steenkiste, B., Ronda, G., Wensing, M., Stoffers, J., Elwyn, G. J., Grol, R. P. T. M., & van der Weijden, T. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-9 · Cited by 54

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study

Khutsoane, D., Sharma, S. K., Almustafa, M., Jang, H. C., Azar, S. T., Danciulescu, R., Shestakova, M. V., Ayad, N., Guler, S., Bech, O. M., et al. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00826.x · Cited by 54

Global Variation in the Prevalence of Elevated Cholesterol in Outpatients With Established Vascular Disease or 3 Cardiovascular Risk Factors According to National Indices of Economic Development and Health System Performance

Venkitachalam, L., Wang, K., Porath, A., Corbalan, R. L., Hirsch, A. T., Cohen, D. J., Smith, S. C., Ohman, E. M., Steg, P. G., Bhatt, D. L., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.064378 · Cited by 53

Burden of atherosclerosis improves the prediction of coronary heart disease but not cerebrovascular events: The Rotterdam Study

Elias‐Smale, S. E., Wieberdink, R. G., Odink, A. E., Hofman, A., Hunink, M. G. M., Koudstaal, P. J., Krestin, G. P., Breteler, M. M. B., van der Lugt, A., & Witteman, J. C. M. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr125 · Cited by 53

Relative validity and reproducibility of a 14-item semi-quantitative food frequency questionnaire for cardiovascular prevention

Laviolle, B., le Froger-Bompas, C., Guillo, P., Sevestre, A., Letellier, C., Pouchard, M., Daubert, J., & Paillard, F. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000186625.98604.5d · Cited by 57

Effects of a High-Intensity Exercise Program on Weight Regain and Cardio-metabolic Profile after 3 Years of Bariatric Surgery: A Randomized Trial

Marc-Hernández, A., Ruíz-Tóvar, J., Aracil‐Marco, A., Guillén, S. P., & Moya‐Ramón, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60044-z · Cited by 53

Diabetes and Coronary Risk Equivalency

Grundy, S. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1904 · Cited by 52

Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction

Wattanakit, K., Coresh, J., Muntner, P., Marsh, J., & Folsom, A. R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.047 · Cited by 52

Statins for primary prevention of cardiovascular disease

Byrne, P., Cullinan, J., & Smith, S. M. (2019) · BMJ · doi:10.1136/bmj.l5674 · Cited by 53

Do we diagnose and treat coronary heart disease differently in men and women?

FODOR, J. G., Tzerovska, R., Dorner, T. E., et al. (2004) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-004-0093-9 · Cited by 52

Assessing the Clinical Utility of Biomarkers in Medicine

Parikh, N. I., & Vasan, R. S. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.3.419 · Cited by 52

Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice

Wan, Q. (2006) · BMJ Quality & Safety · doi:10.1136/qshc.2005.014845 · Cited by 52

Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention

Mortensen, M. B., & Falk, E. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw568 · Cited by 52

Efficacy of Different Types of Exercise-Based Cardiac Rehabilitation on Coronary Heart Disease: a Network Meta-analysis

Xia, T., Huang, F., Peng, Y., Huang, B., Pu, X., Yang, Y., Chai, H., & Chen, M. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4636-y · Cited by 60

Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease

Mesquita, M. D. C. F., Demulder, A., Damry, N., Mélot, C., Wittersheim, E., Willems, D., Dratwa, M., & Bergmann, P. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.075 · Cited by 51

Self-efficacy in patients with clinical manifestations of vascular diseases

Sol, B. G. M., van der Graaf, Y., van der Bijl, J. J., Goessens, N. B. G., & Visseren, F. L. J. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2005.05.011 · Cited by 52

Inhibitors and enablers of physical activity in multiethnic hypertensive patients: qualitative study

Beune, E., Haafkens, J. A., Agyemang, C. O., & Bindels, P. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.61 · Cited by 55

Error propagation in calculated ratios

Holmes, D. T., & Buhr, K. A. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.12.014 · Cited by 51

Docosahexaenoic Acid Supplementation, Vascular Function and Risk Factors for Cardiovascular Disease: A Randomized Controlled Trial in Young Adults

Singhal, A., Lanigan, J., Storry, C., Low, S., Birbara, T., Lucas, A., & Deanfield, J. E. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000283 · Cited by 50

Cholesterol-Lowering Agents: Statins—For Everyone?

Hadjiphilippou, S., & Ray, K. K. (2019) · Circulation Research · doi:10.1161/circresaha.118.313245 · Cited by 49

Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy

Presta, V., Figliuzzi, I., Miceli, F., Coluccia, R., Fogacci, F., Cicero, A. F. G., Ferrucci, A., Borghi, C., Volpe, M., Tocci, G., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.03.017 · Cited by 51

Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease

Cruz-Fernández, J. M., Bedarida, G., Adgey, J., Allen, C., Johnson‐Levonas, A. O., & Massaad, R. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00565.x · Cited by 52

Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study

Donfrancesco, C., Palleschi, S., Palmieri, L., Rossi, B., Noce, C. L., Pannozzo, F., Spoto, B., Tripepi, G., Zoccali, C., & Giampaoli, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078475 · Cited by 51

Thresholds for normal blood pressure and serum cholesterol: Fig 1

Westin, S., & Heath, I. (2005) · BMJ · doi:10.1136/bmj.330.7506.1461 · Cited by 51

ESC Study Group of Sports Cardiology Recommendations for participation in leisure-time physical activities and competitive sports for patients with hypertension

Fagard, R. H., Björnstad, H. H., Börjesson, M., Carré, F., Deligiannis, A. P., & Vanhees, L. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000174827.79645.f5 · Cited by 51

Who should receive a statin these days? Lessons from recent clinical trials

SHEPHERD, J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01700.x · Cited by 50

Riesgo cardiovascular del SCORE comparado con el de Framingham. Consecuencias del cambio propuesto por las Sociedades Europeas

Galán, A. M., García, F. A., Taix, M. F., Ros, X. A., Martí, E. A., & Gil, Á. C. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)75330-0 · Cited by 51

2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations

Zeitouni, M., Sabouret, P. F., Kernéis, M., Silvain, J., Collet, J., Bruckert, É., & Montalescot, G. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa077 · Cited by 56

The International Pandemic of Chronic Cardiovascular Disease

McDermott, M. M. (2007) · JAMA · doi:10.1001/jama.297.11.1253 · Cited by 48

The Performance of Blood Pressure and other Cardiovascular Risk Factors as Screening Tests for Ischaemic Heart Disease and Stroke

Law, M. R., Wald, N., & Morris, J. K. (2004) · Journal of Medical Screening · doi:10.1177/096914130301100102 · Cited by 50

Pre‐analytical factors and measurement uncertainty

Kouri, T., Siloaho, M., Pohjavaara, S., et al. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510500208332 · Cited by 50

Barriers to effective implementation of guideline recommendations

Erhardt, L. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.004 · Cited by 49

Psychosocial considerations in the european guidelines for prevention of cardiovascular diseases in clinical practice: third joint task force

Orth‐Gomér, K., Albus, C., Bagés, N., DeBacker, G., Deter, H., Herrmann‐Lingen, C., Oldenburg, B. F., Sans, S., Williams, R. B., & Schneiderman, N. (2005) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1203_2 · Cited by 48

Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease

Farnier, M., Volpe, M., Massaad, R., Davies, M. J., & Allen, C. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.022 · Cited by 50

Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy

Schmidt‐Lucke, C., Fichtlscherer, S., Rössig, L., Kämper, U., & Dimmeler, S. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.007 · Cited by 49

Estimation of 10-year risk of fatal cardiovascular disease and coronary heart disease in Iceland with results comparable with those of the Systematic Coronary Risk Evaluation project

Aspelund, T., Þorgeirsson, G., Sigurðsson, G., & Gudnason, V. G. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32825fea6d · Cited by 49

Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality

Pedersen, S. S., Denollet, J., Ong, A. T. L., Sonnenschein, K., Erdman, R. A. M., Serruys, P. W. J. C., & van Domburg, R. T. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328045c282 · Cited by 49

Efficacy of Viabahn® in the Treatment of Severe Superficial Femoral Artery Lesions: Which Factors Influence Long-term Patency?

Alimi, Y., Hakam, Z., Hartung, O., et al. (2007) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2007.09.005 · Cited by 49

Identifying genes for coronary artery disease: An idea whose time has come

Roberts, R., Stewart, A. F. R., Wells, G. A., Williams, K., Kavaslar, N., & McPherson, R. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)71000-0 · Cited by 49

Evaluating the causal relevance of diverse risk markers: horizontal systematic review

Kuper, H., Nicholson, A., Mika Kivimaki, B., Aitsi-Selmi, A., Cavalleri, G. L., Deanfield, J. E., Heuschmann, P. U., Jouven, X., Malyutina, S. K., Mayosi, B. M., et al. (2009) · BMJ · doi:10.1136/bmj.b4265 · Cited by 48

Drug Treatment of Hyperlipidaemia

Toth, P. P. (2010) · Drugs · doi:10.2165/10898610-000000000-00000 · Cited by 49

Being at risk for cardiovascular disease: Perceptions and preventive behavior in people with and without a known genetic predisposition

Claassen, L., Henneman, L., van der Weijden, T., Marteau, T. M., & Timmermans, D. R. M. (2012) · Psychology Health & Medicine · doi:10.1080/13548506.2011.644246 · Cited by 48

Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice

Vittorini, S., & Clerico, A. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.188 · Cited by 47

Rendimiento de la estimación del riesgo cardiovascular en España mediante la utilización de distintas funciones

Comín, E., Solanas, P., Cabezas, C., Subirana, I., Ramos, R., Badía, J. G., Cordón, F., Grau, M., Vila, J., & Marrugat, J. (2007) · Revista Española de Cardiología · doi:10.1157/13108274 · Cited by 48

Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: The DECODE Study

Zhang, L., Qiao, Q., Tuomilehto, J. O., Hammar, N., Alberti, K. G. M. M., Eliasson, M., Heine, R. J., Stehouwer, C. D. A., & Ruotolo, G. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.08.022 · Cited by 48

Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial

Geluk, C. A., Asselbergs, F. W., Hillege, H. L., Bakker, S. J. L., de Jong, P. E., Zijlstra, F., & van Gilst, W. H. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi253 · Cited by 48

Lipid distributions in the Global Diagnostics Network across five continents

Martin, S. S., Niles, J. K., Kaufman, H. W., Awan, Z. A., Elgaddar, O., Choi, R., Ahn, S., Verma, R., Nagarajan, M., Don-Wauchope, A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad371 · Cited by 47

Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study

Pétursson, H., Sigurdsson, J. A., Bengtsson, C., Nilsen, T. I. L., & Getz, L. (2011) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2011.01767.x · Cited by 48

Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel

Yousef, A., Arafat, T., Bulatova, N., et al. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00936.x · Cited by 47

Patient education for the prevention of diabetic foot ulcers

Gershater, M. A., Pilhammar, E., Apelqvist, J., & Alm‐Roijer, C. (2011) · European Diabetes Nursing · doi:10.1002/edn.189 · Cited by 46

Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease

Barrios, V., Amabile, N., Paganelli, F. F., Chen, J.-W., Allen, C., Johnson‐Levonas, A. O., Massaad, R., & Vandormael, K. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00714.x · Cited by 48

Statins are effective in treating dyslipidemia among psychiatric patients using second-generation antipsychotic agents

Ojala, K., Repo-Tiihonen, E., Tiihonen, J., & Niskanen, L. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107077815 · Cited by 43

Homocysteine and serum lipids concentration in male war veterans with posttraumatic stress disorder

Jendričko, T., Vidović, A., Grubišić-Ilić, M., Romić, Ž., Kovačić, Z., & Kozarić‐Kovačić, D. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.002 · Cited by 46

Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials

Khoueiry, G., Rafeh, N. A., Sullivan, E., Saiful, F. B., Jaffery, Z., Kenigsberg, D. N., Krishnan, S., Khanal, S., Bekheit, S., & Kowalski, M. (2013) · Heart & Lung · doi:10.1016/j.hrtlng.2013.03.006 · Cited by 46

Clinical profile of acute myocardial infarction in elderly patients

Bhatia, L. C., & Naik, R. (2013) · Journal of Cardiovascular Disease Research · doi:10.1016/j.jcdr.2012.07.003 · Cited by 46

Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly

Lapi, F., Marconi, E., Simonetti, M., Baldo, V., Rossi, A., Sessa, A., & Cricelli, C. A. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1622418 · Cited by 47

Guía de Práctica Clínica para el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST

de Cardiología, G. D. T. P. E. D. Y. T. D. S. C. A. S. E. D. S. S. D. L. S. E. (2007) · Revista Española de Cardiología · doi:10.1157/13111518 · Cited by 46

Cardiovascular risk and the omega-3 index

von Schacky, C., & Harris, W. S. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000289273.87803.87 · Cited by 47

Waist Circumference and BMI Cut‐off Based on 10‐year Cardiovascular Risk: Evidence for “Central Pre‐Obesity”

Ko, G. T. C., & Tang, J. (2007) · Obesity · doi:10.1038/oby.2007.336 · Cited by 46

The results of a worksite health promotion programme in Kuala Lumpur, Malaysia

Moy, F. M., Sallam, A. A., & Wong, M. L. (2006) · Health Promotion International · doi:10.1093/heapro/dal031 · Cited by 46

Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice

van der Weijden, T., Bos, L. B., & Loon, M. S. K.-V. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32830b35f6 · Cited by 45

(n-3) Fatty Acid Content of Red Blood Cells Does Not Predict Risk of Future Cardiovascular Events following an Acute Coronary Syndrome

Aarsetoey, H., Pönitz, V., Grundt, H., Staines, H., Harris, W. S., & Nilsen, D. W. T. (2009) · Journal of Nutrition · doi:10.3945/jn.108.096446 · Cited by 45

Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study)

Mancia, G., Rosei, E. A., Ambrosioni, E., Avino, F., Carolei, A., Daccò, M., Giacomo, G. D., Ferri, C., Grazioli, I., Melzi, G., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283410404 · Cited by 42

Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases

Ming, E. E., Davidson, M. H., Gandhi, S. K., Marotti, M., Miles, C., Ke, X., & McKenney, J. M. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.10.007 · Cited by 45

Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes

Betteridge, D. J., & Gibson, M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02095.x · Cited by 45

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS)

Hitman, G. A., Colhoun, H. M., Newman, C. B., Szarek, M. J., Betteridge, D. J., Durrington, P. N., Fuller, J., Livingstone, S. J., Neil, H. A. W., & on behalf of the CARDS Investigators (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02268.x · Cited by 45

The influence of statin characteristics on their safety and tolerability

Angelis, G. D. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.00355.x · Cited by 46

Committee and Task Force Reports: Youth and Families Task Force Report

James, S., Jordan, K., Lasser, J. S., et al. (1997) · PsycEXTRA Dataset · doi:10.1037/e413432005-005

Ethnic Minority Elderly: A Task Force Report of the American Psychiatric Association

Busse, E. W. (1995) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199524310-00013 · Cited by 1

Committee and Task Force Reports: Task Force on Aging

Carlson, H. M., & David, S. (2004) · PsycEXTRA Dataset · doi:10.1037/e373992004-024

Committee and Task Force News: Task Force on Students-at-Risk

Kaslow, F. W., & Olson, D. L. (1991) · PsycEXTRA Dataset · doi:10.1037/e410102005-024 · Cited by 1

Update From the American Psychiatry Association's Task Force on Electroconvulsive Therapy

McDonald, W. M., Prudic, J., McCall, W. V., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.078 · Cited by 3